Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review.

CMR ESUS MRI reclassification value

Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
31 Jul 2023
Historique:
pubmed: 12 7 2023
medline: 12 7 2023
entrez: 12 7 2023
Statut: aheadofprint

Résumé

Embolic stroke of undetermined source (ESUS) refers to ischemic stroke where the underlying cause of thromboembolism cannot be found despite the recommended diagnostic workup. Unidentified source of emboli hinders clinical decision-making and patient management with detrimental consequences on long-term prognosis. The rapid development and versatility of magnetic resonance imaging (MRI) make it an appealing addition to the diagnostic routine of patients with ESUS for the assessment of potential vascular and cardiac embolic sources. To review the use of MRI in the identification of cardiac and vascular embolic sources in ESUS and to assess the reclassification value of MRI examinations added to the conventional workup of ESUS. We reviewed the use of cardiac and vascular MRI for the identification of a variety of embolic sources associated with ESUS, including atrial cardiomyopathy, left ventricular pathologies, and supracervical atherosclerosis in carotid and intracranial arteries and in distal thoracic aorta. The additional reclassification after MRI examinations added to the workup of patients with ESUS ranged from 6.1% to 82.3% and varied depending on the combination of imaging modalities. MRI techniques allow us to identify additional cardiac and vascular embolic sources and may further decrease the prevalence of patients with the diagnosis of ESUS.

Sections du résumé

BACKGROUND UNASSIGNED
Embolic stroke of undetermined source (ESUS) refers to ischemic stroke where the underlying cause of thromboembolism cannot be found despite the recommended diagnostic workup. Unidentified source of emboli hinders clinical decision-making and patient management with detrimental consequences on long-term prognosis. The rapid development and versatility of magnetic resonance imaging (MRI) make it an appealing addition to the diagnostic routine of patients with ESUS for the assessment of potential vascular and cardiac embolic sources.
AIMS UNASSIGNED
To review the use of MRI in the identification of cardiac and vascular embolic sources in ESUS and to assess the reclassification value of MRI examinations added to the conventional workup of ESUS.
SUMMARY OF REVIEW UNASSIGNED
We reviewed the use of cardiac and vascular MRI for the identification of a variety of embolic sources associated with ESUS, including atrial cardiomyopathy, left ventricular pathologies, and supracervical atherosclerosis in carotid and intracranial arteries and in distal thoracic aorta. The additional reclassification after MRI examinations added to the workup of patients with ESUS ranged from 6.1% to 82.3% and varied depending on the combination of imaging modalities.
CONCLUSION UNASSIGNED
MRI techniques allow us to identify additional cardiac and vascular embolic sources and may further decrease the prevalence of patients with the diagnosis of ESUS.

Identifiants

pubmed: 37435743
doi: 10.1177/17474930231189946
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

17474930231189946

Auteurs

Natallia Khenkina (N)

Postgraduate School of Diagnostic and Interventional Radiology, University of Milan, Milan, Italy.

Alberto Aimo (A)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Iacopo Fabiani (I)

Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Pier Giorgio Masci (PG)

School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.

Dimitrios Sagris (D)

Liverpool Centre of Cardiovascular Sciences, University of Liverpool, Liverpool, UK.

Steven E Williams (SE)

The University of Edinburgh, Edinburgh, UK.

George Mavraganis (G)

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

Hui-Sheng Chen (HS)

Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.

Max Wintermark (M)

Department of Radiology, Stanford University, Stanford, CA, USA.

Patrik Michel (P)

Stroke Center, Neurology Service, Department of Clinical Neurosciences, Lausanne University Hospital, Lausanne, Switzerland.

George Ntaios (G)

Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Georgios Georgiopoulos (G)

School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

Classifications MeSH